DAIC

FEBRUARY 14, 2024

milla1cf Wed, 02/14/2024 - 18:53 February 14, 2024 — The American College of Cardiology ’s newest registry offers data-driven insights on cardiac procedures performed in the ambulatory surgery setting through its first-of-its-kind dashboard.

Outpatient 105

Outpatient Hospital Reimbursement Medicaid 105

GEMMS

APRIL 8, 2024

Below, we will explore the 2024 changes to MIPS and how interoperability features in EHR software can revolutionize how cardiology providers approach MIPS reporting changes. This decision will likely relieve many eligible clinicians (ECs) affected by MIPS, including cardiologists who rely on accurate reporting for optimal reimbursement.

Medicare 52

Medicare Innovation Medicaid Patient Care 52

DAIC

MARCH 28, 2025

vii Similarly, recent increases in Medicare reimbursement rates for CCTA are a positive step towards making this technology more accessible. 2024,November 8). a huge win: CMS significantly increases Medicare payments for cardiac CT. 2012) 380:2095128. 10.1016/S0140-6736(12)61728-0. link] iv IMV.2023 v Walter, M.

Technology 59

Technology Coronary Artery Disease Atrial Fibrillation Medicare 59

DAIC

JULY 18, 2024

CPT codes are widely used by government payers, including Medicare and Medicaid, and commercial insurance companies to identify healthcare services and procedures for reimbursement. In accordance with the AMA semi-annual early release schedule, the new codes will be effective January 1st, 2025 and published in the 2025 CPT Code book.

Reimbursement 105

Reimbursement Technology Electrocardiogram Medicaid 105

DAIC

MARCH 13, 2024

Getty Images milla1cf Wed, 03/13/2024 - 16:49 March 13, 2024 — BioCardia, Inc. , CMS has reviewed the CardiAMP Heart Failure II Trial and approved the investigational product, related and routine items and services for purposes of Medicare coverage. CAUTION - Limited by United States law to investigational use.

CMS 111

CMS Heart Failure Reimbursement Quality of Life 111

DAIC

JULY 25, 2024

mtaschetta-millane Thu, 07/25/2024 - 09:08 July 25, 2024 — BioCardia, Inc. , The CardiAMP clinical development for heart failure is supported by the Maryland Stem Cell Research Fund and is reimbursed by Center for Medicare and Medicaid Services (CMS) for both treatment and control procedures.

Heart Failure 111

Heart Failure Quality of Life CMS Reimbursement 111

DAIC

MARCH 7, 2024

The data was presented today by Amish Raval , MD, Director of Clinical Cardiovascular Research and Professor of Medicine at the University of Wisconsin-Madison at the Technology and Heart Failure Therapeutics (THT) 2024 annual meeting. The CardiAMP HF II trial is expected to similarly secure CMS reimbursement.

Heart Failure 105

Heart Failure Biomarkers Reimbursement CMS 105

DAIC

MARCH 3, 2025

GE HealthCare will mark the commercial launch of Flyrcado at the annual American College of Cardiology congress in Chicago from March 29-31, 2025, and expects to receive pass-through status from the US Centers for Medicaid and Medicare (CMS) shortly thereafter, enabling separate reimbursement for Flyrcado in the hospital outpatient setting.

Coronary Artery Disease 52

Coronary Artery Disease Ischemia Exercise Hospital 52

American College of Cardiology

NOVEMBER 7, 2024

The Centers for Medicare and Medicaid Services (CMS) released the 2025 Medicare Physician Fee Schedule (PFS) final rule on Nov. Of note, the 2025 PFS conversion factor is $32.3465, reduced 2.83% from $33.2875 in 2024.

Medicare 40

Medicare Reimbursement CMS Medicaid 40